INITIAL OUTCOMES OF SURGICAL TREATMENT IN PATIENTS WITH MULTILEVEL CERVICAL SPONDYLOTIC MYELOPATHY AT BACH MAI HOSPITAL

Nguyễn Văn Trung1,2,, Đào Xuân Thành1,2, Nguyễn Lê Bảo Tiến3, Hoàng Gia Du2
1 Hanoi Medical University
2 Bach Mai Hospital
3 Vietnam-Germany Friendship Hospital

Main Article Content

Abstract

The study's objectives were to evaluate the initial outcomes of surgical treatment of multilevel cervical spondylotic myelopathy. Research Methods: An uncontrolled clinical intervention study evaluating outcomes before and after surgeryincluded 30 consecutive patients who underwent surgical treatment for multilevel cervical spondylotic myelopathy (M-CSM) from June, 2019 to Aug, 2021 at Orthopedic and Spine department, Bach Mai hospital. Results: Mean age 63.10 ± 9.82 (from 39 - 79 years old), 19 male patients (63.3%), 11 female patients (36.7%). Male/Female ratio ≈ 2/1. The average follow-up time was 13.13 months.The average mJOA score preoperative, postoperative, and follow-up was 10.17, 13.53, and 16.17, respectively. The average cervical myelopathy recovery rate after surgery and follow-up time was 45.46% and 76.69%, respectively. The patient with the onset ≥6 months had a worse rate of cervical myelopathy recovery at the time of final follow-up (p=0.021). Regional Cobb angle and C2-C7 Cobb angle of the group of patients with anterior surgery improved significantly compared to patients with posterior surgery (p = 0.006 and 0.029, respectively). The posterior approach had a shorter operation time but more blood loss than the anterior approach (p<0.001). Conclusion: Initial surgical outcomes for multilevel cervical spondylotic myelopathy were good at two approaches.

Article Details

References

1. Nouri, A., et al., Degenerative Cervical Myelopathy: A Brief Review of Past Perspectives, Present Developments, and Future Directions. J Clin Med, 2020. 9(2).
2. Nouri, A., et al., Degenerative Cervical Myelopathy: Epidemiology, Genetics, and Pathogenesis. Spine (Phila Pa 1976), 2015. 40(12): p. E675-93.
3. Zileli, M., et al., Outcome Measures and Variables Affecting Prognosis of Cervical Spondylotic Myelopathy: WFNS Spine Committee Recommendations. Neurospine, 2019. 16(3): p. 435-447.
4. Lad, S.P., et al., National trends in spinal fusion for cervical spondylotic myelopathy. Surg Neurol, 2009. 71(1): p. 66-9; discussion 69.
5. Zhang, R.J., et al., Clinical features and surgical outcomes of cervical spondylotic myelopathy in patients of different ages: a retrospective study. Spinal Cord, 2018. 56(1): p. 7-13.
6. Bajamal, A.H., et al., Posterior Surgical Techniques for Cervical Spondylotic Myelopathy: WFNS Spine Committee Recommendations. Neurospine, 2019. 16(3): p. 421-434.
7. Tetreault, L., et al., The modified Japanese Orthopaedic Association scale: establishing criteria for mild, moderate and severe impairment in patients with degenerative cervical myelopathy. Eur Spine J, 2017. 26(1): p. 78-84.
8. Hirabayashi, K. and K. Satomi, Operative procedure and results of expansive open-door laminoplasty. Spine (Phila Pa 1976), 1988. 13(7): p. 870-6.
9. Nouri, A., et al., Magnetic resonance imaging assessment of degenerative cervical myelopathy: a review of structural changes and measurement techniques. Neurosurg Focus, 2016. 40(6): p. E5.
10.Tetreault, L.A., A. Karpova, and M.G. Fehlings, Predictors of outcome in patients with degenerative cervical spondylotic myelopathy undergoing surgical treatment: results of a systematic review. Eur Spine J, 2015. 24 Suppl 2: p. 236-51.